| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 0.08 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.24 | 0.0005 |